pmc-enju-pas Home  

PMC:2817507 / 13317-14289 JSONTXT 10 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T6762 0-13 NN denotes Transcription
T6763 14-20 NN denotes factor
T6764 21-28 JJ denotes nuclear
T6765 29-43 NN denotes factor-kappa-B
T6766 44-45 -LRB- denotes (
T6767 45-49 NN denotes NFκB
T6768 49-50 -RRB- denotes )
T6769 51-53 VB denotes is
T6770 54-56 DT denotes an
T6771 57-66 JJ denotes important
T6772 67-74 JJ denotes nuclear
T6773 75-88 NN denotes transcription
T6774 89-95 NN denotes factor
T6775 95-96 -COMMA- denotes ,
T6776 97-102 WDT denotes which
T6777 103-112 VB denotes initiates
T6778 113-126 NN denotes transcription
T6779 127-129 IN denotes of
T6780 130-135 NN denotes genes
T6781 136-146 VB denotes associated
T6782 147-151 IN denotes with
T6783 152-158 JJ denotes immune
T6784 159-168 NN denotes responses
T6785 169-172 CC denotes and
T6786 173-185 NN denotes inflammation
T6787 186-187 -LRB- denotes [
T6788 187-189 CD denotes 12
T6789 189-190 -COMMA- denotes ,
T6790 191-193 CD denotes 13
T6791 193-194 -RRB- denotes ]
T6792 195-198 CC denotes and
T6793 199-203 RB denotes also
T6794 204-209 VB denotes plays
T6795 210-211 DT denotes a
T6796 212-215 JJ denotes key
T6797 216-220 NN denotes role
T6798 221-223 IN denotes in
T6799 224-234 VB denotes regulating
T6800 235-247 NN denotes inflammation
T6801 248-250 IN denotes in
T6802 251-256 NN denotes brain
T6803 257-268 NN denotes pathologies
T6804 270-272 PRP denotes It
T6805 273-276 VB denotes has
T6806 277-281 VB denotes been
T6807 282-290 VB denotes reported
T6808 291-295 IN denotes that
T6809 296-300 NN denotes NFκB
T6810 301-310 VB denotes increased
T6811 311-313 IN denotes in
T6812 314-317 DT denotes the
T6813 318-324 NN denotes region
T6814 325-327 IN denotes of
T6815 328-340 NN denotes perihematoma
T6816 341-346 IN denotes after
T6817 347-350 NN denotes ICH
T6818 351-352 -LRB- denotes [
T6819 352-354 CD denotes 14
T6820 354-355 -RRB- denotes ]
T6821 357-361 NN denotes NFκB
T6822 362-372 NN denotes activation
T6823 373-379 VB denotes occurs
T6824 380-386 IN denotes within
T6825 387-394 NN denotes minutes
T6826 395-398 CC denotes and
T6827 399-407 VB denotes persists
T6828 408-411 IN denotes for
T6829 412-414 IN denotes at
T6830 415-420 JJ denotes least
T6831 421-422 DT denotes a
T6832 423-427 NN denotes week
T6833 428-430 IN denotes in
T6834 431-439 NN denotes response
T6835 440-442 TO denotes to
T6836 443-446 NN denotes ICH
T6837 446-447 -COMMA- denotes ,
T6838 448-453 WDT denotes which
T6839 454-456 VB denotes is
T6840 457-467 VB denotes associated
T6841 468-472 IN denotes with
T6842 473-476 DT denotes the
T6843 477-487 NN denotes expression
T6844 488-490 IN denotes of
T6845 491-499 VB denotes selected
T6846 500-506 NN denotes target
T6847 507-512 NN denotes genes
T6848 513-514 -LRB- denotes [
T6849 514-516 CD denotes 15
T6850 516-517 -RRB- denotes ]
T6851 519-529 NN denotes Activation
T6852 530-532 IN denotes of
T6853 533-537 NN denotes NFκB
T6854 538-547 VB denotes initiates
T6855 548-560 JJ denotes inflammatory
T6856 561-570 NN denotes responses
T6857 571-574 CC denotes and
T6858 575-586 VB denotes contributes
T6859 587-589 TO denotes to
T6860 590-593 DT denotes the
T6861 594-606 NN denotes pathobiology
T6862 607-609 IN denotes of
T6863 610-622 JJ denotes perilesional
T6864 623-627 NN denotes cell
T6865 628-633 NN denotes death
T6866 634-639 IN denotes after
T6867 640-643 NN denotes ICH
T6868 644-645 -LRB- denotes [
T6869 645-647 CD denotes 16
T6870 647-648 -RRB- denotes ]
T6871 650-660 NN denotes Inhibition
T6872 661-663 IN denotes of
T6873 664-668 NN denotes NFκB
T6874 669-677 NN denotes activity
T6875 678-681 VB denotes has
T6876 682-686 VB denotes been
T6877 687-692 VB denotes shown
T6878 693-695 TO denotes to
T6879 696-700 VB denotes have
T6880 701-702 DT denotes a
T6881 703-714 JJ denotes therapeutic
T6882 715-721 NN denotes effect
T6883 722-724 IN denotes on
T6884 725-737 JJ denotes experimental
T6885 738-741 NN denotes ICH
T6886 741-742 -COMMA- denotes ,
T6887 743-747 JJ denotes such
T6888 748-750 IN denotes as
T6889 751-757 NN denotes reduce
T6890 758-770 NN denotes inflammation
T6891 770-771 -COMMA- denotes ,
T6892 772-782 JJ denotes behavioral
T6893 783-794 NN denotes dysfunction
T6894 794-795 -COMMA- denotes ,
T6895 796-799 CC denotes and
T6896 800-808 JJ denotes neuronal
T6897 809-815 NN denotes damage
T6898 816-824 VB denotes produced
T6899 825-827 IN denotes by
T6900 828-831 NN denotes ICH
T6901 832-833 -LRB- denotes [
T6902 833-835 CD denotes 17
T6903 835-836 -RRB- denotes ]
T6904 838-841 DT denotes The
T6905 842-851 NN denotes knowledge
T6906 852-857 IN denotes about
T6907 858-861 WRB denotes how
T6908 862-866 NN denotes NFκB
T6909 867-869 VB denotes is
T6910 870-879 VB denotes activated
T6911 880-882 IN denotes in
T6912 883-886 DT denotes the
T6913 887-892 NN denotes brain
T6914 893-902 VB denotes subjected
T6915 903-905 TO denotes to
T6916 906-909 NN denotes ICH
T6917 910-912 VB denotes is
T6918 913-921 JJ denotes critical
T6919 922-925 IN denotes for
T6920 926-933 VB denotes seeking
T6921 934-935 DT denotes a
T6922 936-939 JJ denotes new
T6923 940-955 JJ denotes neuroprotective
T6924 956-962 NN denotes method
T6925 963-966 IN denotes for
T6926 967-970 NN denotes ICH
R4939 T6765 T6762 arg1Of factor-kappa-B,Transcription
R4940 T6765 T6763 arg1Of factor-kappa-B,factor
R4941 T6765 T6764 arg1Of factor-kappa-B,nuclear
R4942 T6765 T6766 arg1Of factor-kappa-B,(
R4943 T6765 T6769 arg1Of factor-kappa-B,is
R4944 T6767 T6766 arg2Of NFκB,(
R4945 T6768 T6766 arg3Of ),(
R4946 T6774 T6769 arg2Of factor,is
R4947 T6774 T6770 arg1Of factor,an
R4948 T6774 T6771 arg1Of factor,important
R4949 T6774 T6772 arg1Of factor,nuclear
R4950 T6774 T6773 arg1Of factor,transcription
R4951 T6774 T6775 arg1Of factor,","
R4952 T6774 T6776 arg1Of factor,which
R4953 T6774 T6777 arg1Of factor,initiates
R4954 T6774 T6794 arg1Of factor,plays
R4955 T6774 T6799 arg1Of factor,regulating
R4956 T6777 T6792 arg1Of initiates,and
R4957 T6778 T6777 arg2Of transcription,initiates
R4958 T6778 T6779 arg1Of transcription,of
R4959 T6780 T6779 arg2Of genes,of
R4960 T6780 T6781 arg2Of genes,associated
R4961 T6781 T6782 arg1Of associated,with
R4962 T6781 T6787 arg1Of associated,[
R4963 T6784 T6783 arg1Of responses,immune
R4964 T6784 T6785 arg1Of responses,and
R4965 T6785 T6782 arg2Of and,with
R4966 T6786 T6785 arg2Of inflammation,and
R4967 T6788 T6789 arg1Of 12,","
R4968 T6789 T6787 arg2Of ",",[
R4969 T6790 T6789 arg2Of 13,","
R4970 T6791 T6787 arg3Of ],[
R4971 T6794 T6792 arg2Of plays,and
R4972 T6794 T6793 arg1Of plays,also
R4973 T6794 T6798 arg1Of plays,in
R4974 T6797 T6794 arg2Of role,plays
R4975 T6797 T6795 arg1Of role,a
R4976 T6797 T6796 arg1Of role,key
R4977 T6799 T6798 arg2Of regulating,in
R4978 T6799 T6801 arg1Of regulating,in
R4979 T6800 T6799 arg2Of inflammation,regulating
R4980 T6803 T6801 arg2Of pathologies,in
R4981 T6803 T6802 arg1Of pathologies,brain
R4982 T6804 T6805 arg1Of It,has
R4983 T6804 T6806 arg1Of It,been
R4984 T6804 T6807 arg2Of It,reported
R4985 T6807 T6805 arg2Of reported,has
R4986 T6807 T6806 arg2Of reported,been
R4987 T6809 T6810 arg1Of NFκB,increased
R4988 T6810 T6807 arg3Of increased,reported
R4989 T6810 T6808 arg1Of increased,that
R4990 T6810 T6811 arg1Of increased,in
R4991 T6813 T6811 arg2Of region,in
R4992 T6813 T6812 arg1Of region,the
R4993 T6813 T6814 arg1Of region,of
R4994 T6813 T6816 arg1Of region,after
R4995 T6815 T6814 arg2Of perihematoma,of
R4996 T6817 T6816 arg2Of ICH,after
R4997 T6817 T6818 arg1Of ICH,[
R4998 T6819 T6818 arg2Of 14,[
R4999 T6820 T6818 arg3Of ],[
R5000 T6822 T6821 arg1Of activation,NFκB
R5001 T6822 T6823 arg1Of activation,occurs
R5002 T6822 T6827 arg1Of activation,persists
R5003 T6823 T6824 arg1Of occurs,within
R5004 T6823 T6826 arg1Of occurs,and
R5005 T6825 T6824 arg2Of minutes,within
R5006 T6827 T6826 arg2Of persists,and
R5007 T6827 T6828 arg1Of persists,for
R5008 T6830 T6829 arg1Of least,at
R5009 T6832 T6828 arg2Of week,for
R5010 T6832 T6830 arg1Of week,least
R5011 T6832 T6831 arg1Of week,a
R5012 T6832 T6833 arg1Of week,in
R5013 T6832 T6837 arg1Of week,","
R5014 T6832 T6838 arg1Of week,which
R5015 T6832 T6839 arg1Of week,is
R5016 T6832 T6840 arg2Of week,associated
R5017 T6833 T6835 arg1Of in,to
R5018 T6834 T6833 arg2Of response,in
R5019 T6836 T6833 arg3Of ICH,in
R5020 T6840 T6839 arg2Of associated,is
R5021 T6840 T6841 arg1Of associated,with
R5022 T6843 T6841 arg2Of expression,with
R5023 T6843 T6842 arg1Of expression,the
R5024 T6843 T6844 arg1Of expression,of
R5025 T6847 T6844 arg2Of genes,of
R5026 T6847 T6845 arg2Of genes,selected
R5027 T6847 T6846 arg1Of genes,target
R5028 T6847 T6848 arg1Of genes,[
R5029 T6849 T6848 arg2Of 15,[
R5030 T6850 T6848 arg3Of ],[
R5031 T6851 T6852 arg1Of Activation,of
R5032 T6851 T6854 arg1Of Activation,initiates
R5033 T6851 T6858 arg1Of Activation,contributes
R5034 T6853 T6852 arg2Of NFκB,of
R5035 T6854 T6857 arg1Of initiates,and
R5036 T6856 T6854 arg2Of responses,initiates
R5037 T6856 T6855 arg1Of responses,inflammatory
R5038 T6857 T6868 arg1Of and,[
R5039 T6858 T6857 arg2Of contributes,and
R5040 T6858 T6859 arg1Of contributes,to
R5041 T6858 T6866 arg1Of contributes,after
R5042 T6861 T6859 arg2Of pathobiology,to
R5043 T6861 T6860 arg1Of pathobiology,the
R5044 T6861 T6862 arg1Of pathobiology,of
R5045 T6865 T6862 arg2Of death,of
R5046 T6865 T6863 arg1Of death,perilesional
R5047 T6865 T6864 arg1Of death,cell
R5048 T6867 T6866 arg2Of ICH,after
R5049 T6869 T6868 arg2Of 16,[
R5050 T6870 T6868 arg3Of ],[
R5051 T6871 T6872 arg1Of Inhibition,of
R5052 T6871 T6875 arg1Of Inhibition,has
R5053 T6871 T6876 arg1Of Inhibition,been
R5054 T6871 T6877 arg2Of Inhibition,shown
R5055 T6871 T6879 arg1Of Inhibition,have
R5056 T6874 T6872 arg2Of activity,of
R5057 T6874 T6873 arg1Of activity,NFκB
R5058 T6877 T6875 arg2Of shown,has
R5059 T6877 T6876 arg2Of shown,been
R5060 T6879 T6877 arg3Of have,shown
R5061 T6879 T6878 arg1Of have,to
R5062 T6882 T6879 arg2Of effect,have
R5063 T6882 T6880 arg1Of effect,a
R5064 T6882 T6881 arg1Of effect,therapeutic
R5065 T6882 T6883 arg1Of effect,on
R5066 T6882 T6886 arg1Of effect,","
R5067 T6882 T6888 arg1Of effect,as
R5068 T6885 T6883 arg2Of ICH,on
R5069 T6885 T6884 arg1Of ICH,experimental
R5070 T6888 T6887 arg1Of as,such
R5071 T6890 T6889 arg1Of inflammation,reduce
R5072 T6890 T6891 arg1Of inflammation,","
R5073 T6891 T6895 arg1Of ",",and
R5074 T6893 T6891 arg2Of dysfunction,","
R5075 T6893 T6892 arg1Of dysfunction,behavioral
R5076 T6895 T6888 arg2Of and,as
R5077 T6895 T6894 arg1Of and,","
R5078 T6897 T6895 arg2Of damage,and
R5079 T6897 T6896 arg1Of damage,neuronal
R5080 T6897 T6898 arg2Of damage,produced
R5081 T6898 T6901 arg1Of produced,[
R5082 T6900 T6898 arg1Of ICH,produced
R5083 T6900 T6899 arg2Of ICH,by
R5084 T6902 T6901 arg2Of 17,[
R5085 T6903 T6901 arg3Of ],[
R5086 T6905 T6904 arg1Of knowledge,The
R5087 T6905 T6906 arg1Of knowledge,about
R5088 T6905 T6917 arg1Of knowledge,is
R5089 T6905 T6918 arg1Of knowledge,critical
R5090 T6907 T6906 arg2Of how,about
R5091 T6908 T6909 arg1Of NFκB,is
R5092 T6908 T6910 arg2Of NFκB,activated
R5093 T6910 T6907 arg1Of activated,how
R5094 T6910 T6909 arg2Of activated,is
R5095 T6910 T6911 arg1Of activated,in
R5096 T6913 T6911 arg2Of brain,in
R5097 T6913 T6912 arg1Of brain,the
R5098 T6913 T6914 arg2Of brain,subjected
R5099 T6914 T6915 arg1Of subjected,to
R5100 T6916 T6915 arg2Of ICH,to
R5101 T6918 T6917 arg2Of critical,is
R5102 T6918 T6919 arg1Of critical,for
R5103 T6920 T6919 arg2Of seeking,for
R5104 T6924 T6920 arg2Of method,seeking
R5105 T6924 T6921 arg1Of method,a
R5106 T6924 T6922 arg1Of method,new
R5107 T6924 T6923 arg1Of method,neuroprotective
R5108 T6924 T6925 arg1Of method,for
R5109 T6926 T6925 arg2Of ICH,for